Idexx Laboratories (IDXX) Total Liabilities (2009 - 2026)

Idexx Laboratories' Total Liabilities history runs 18 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Total Liabilities rose 3.61% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $1.8 billion (up 3.61% YoY), while the FY2025 annual figure was $1.7 billion, up 2.78% from the prior year.
• Total Liabilities for Q1 2026 stood at $1.8 billion, up from $1.7 billion in the prior quarter.
• The five-year high for Total Liabilities was $2.2 billion in Q3 2022, with the low at $1.7 billion in Q4 2024.
• The 5-year median for Total Liabilities is $1.8 billion (2025), against an average of $1.9 billion.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities jumped 32.74% in 2022, then declined 17.36% in 2023.
• Idexx Laboratories' Total Liabilities stood at $2.1 billion in 2022, then decreased by 16.96% to $1.8 billion in 2023, then dropped by 4.35% to $1.7 billion in 2024, then grew by 2.78% to $1.7 billion in 2025, then increased by 4.81% to $1.8 billion in 2026.
• Business Quant data shows IDXX's Total Liabilities at $1.8 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.8 billion in Q3 2025.